American Portfolios Advisors Graphite Bio, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Graphite Bio, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 20 shares of GRPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Holding current value
$0
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$2.82 - $4.24 $56 - $84
20 New
20 $63,000
Q1 2022

Mar 21, 2023
BUY
$5.1 - $13.06 $1,275 - $3,265
250 Added 1250.0%
270 $1.38 Million
Q4 2021

Mar 21, 2023
BUY
$8.41 - $16.71 $2,102 - $4,177
250 Added 1250.0%
270 $3.36 Million

Others Institutions Holding GRPH

# of Institutions
3
Shares Held
637K
Call Options Held
0
Put Options Held
0
View Full List

About Graphite Bio, Inc.

GRPH Quotes by TradingView
  • Ticker GRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,211,200
  • Description
  • Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...
More about GRPH
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email